Ropeginterferon Alfa 2b for Early Myelofibrosis
Clinical trial NCT04988815 · UNKNOWN
Trial details
- NCT number
- NCT04988815
- Sponsor
- The University of Hong Kong
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-01
- Primary completion
- 2025-07-31
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.